Viridian Therapeutics Stock Performance

Viridian Therapeutics Relative Risk vs. Return Landscape

If you would invest  2,750  in Viridian Therapeutics on November 6, 2025 and sell it today you would earn a total of  440.00  from holding Viridian Therapeutics or generate 16.0% return on investment over 90 days. Viridian Therapeutics is currently generating 0.2676% in daily expected returns and assumes 2.0257% risk (volatility on return distribution) over the 90 days horizon. In different words, 18% of stocks are less volatile than Viridian, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 2.7 times more return on investment than the market. However, the company is 2.7 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.11 per unit of risk.

Viridian Therapeutics Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Viridian Therapeutics has a beta of 0.4. This entails as returns on the market go up, Viridian Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Viridian Therapeutics will be expected to be much smaller as well. Additionally Viridian Therapeutics has an alpha of 0.5038, implying that it can generate a 0.5 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Viridian Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Viridian Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 29.34 31.90 34.46 Details

Intrinsic Valuation Low Real High 28.71 35.99 38.55 Details

Naive Forecast Low Next High 29.54 32.10 34.66 Details

16 Analysts Consensus Low Target High 38.11 41.88 46.49 Details

Viridian Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Viridian Therapeutics is not an exception. The market had few large corrections towards the Viridian Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Viridian Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Viridian Therapeutics within the framework of very fundamental risk indicators.

Viridian Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Viridian Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Viridian Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Viridian Therapeutics Price Density Drivers

Viridian Therapeutics Fundamentals Growth

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viridian Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in Viridian Stock, please use our How to Invest in Viridian Therapeutics guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Understanding Viridian Therapeutics requires distinguishing between market price and book value, where the latter reflects Viridian's accounting equity. The concept of intrinsic value - what Viridian Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Viridian Therapeutics' price substantially above or below its fundamental value.

Please note, there is a significant difference between Viridian Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Viridian Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Viridian Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.